Sitting at the helm of Biodesix (Boulder, Colorado) David Brunel, is coming off a banner year for the company and looking at ways to continue the firm's push for success. The CEO spoke to Medical Device Daily ahead of his attendance at the American Society of Clinical Oncology (ASCO: Alexandria, Virginia) conference held over the weekend and early into this week, and said that the company had gained definite traction and had some more milestones in front of it.